**Question:** Which of the following is not an alkylating agent:

A. Methotrexate
B. Cyclophosphamide
C. Thalidomide
D. Fluorouracil

**Core Concept:** Alkylating agents are a class of chemotherapeutic agents that covalently bind to nitrogenous bases of DNA, leading to cross-linking and disruption of DNA replication and transcription. This results in cell cycle arrest, DNA fragmentation, and ultimately cell death. Alkylating agents are broadly classified as nitrogen mustards (e.g., cyclophosphamide) and nitrosoureas (e.g., methotrexate). Thalidomide is a glutamic acid antagonist and immunosuppressant, while fluorouracil is an antimetabolite that interferes with thymidylate synthase and DNA synthesis.

**Why the Correct Answer is Right:** Fluorouracil is a pyrimidine analog that inhibits thymidylate synthase, preventing the synthesis of thymidine monophosphate (TMP), a critical component of DNA and RNA. By inhibiting TMP production, fluorouracil interferes with DNA and RNA synthesis, ultimately causing cell death.

**Why Each Wrong Option is Incorrect:**

A. Methotrexate: A nitrogen mustard alkylating agent that forms a covalent bond with DNA bases, particularly guanine, inhibiting DNA synthesis and repair.
B. Cyclophosphamide: Another nitrogen mustard alkylating agent, cyclophosphamide interferes with DNA synthesis and repair, leading to cell death.
C. Thalidomide: A glutamic acid antagonist, thalidomide's primary action is as an antiemetic and sedative, not related to its alkylating properties.

**Clinical Pearl:** Alkylating agents are crucial in the treatment of several malignancies, including lymphomas, leukemias, and solid tumors. Their mechanism of action and potential side effects should be well-understood by medical students and practitioners.